Dr. Omics Labs at NITI Aayog: Contributing to India's Bioeconomy Vision

⭐ Featured Achievement
Dr. Omics Labs at NITI Aayog: Contributing to India's Bioeconomy Vision

Dr. Deepshikha Satish represented Dr. Omics Labs at NITI Aayog, New Delhi, in a discussion on building India's bioeconomy. The same expertise shapes every Dr. Omics Edu programme.


About this Achievement

A SEAT AT THE NATIONAL TABLE

Dr. Omics Labs, known as "The Doctor of your DNA", was represented at NITI Aayog, the Government of India's apex public policy think tank. Dr. Deepshikha Satish took her seat at the table alongside policymakers, scientists and industry leaders shaping India's biotechnology future. For learners at Dr. Omics Edu, this means one thing: you learn genomics from people who help shape the field at the national level. Dr. Deepshikha Satish, CEO and founder of Dr. Omics Labs, attended a roundtable at NITI Aayog in New Delhi. The session focused on the roadmap for India's bioeconomy and biomanufacturing by 2030. Invitations to NITI Aayog consultations go to organisations with proven domain expertise. Being part of this conversation reflects the standing Dr. Omics Labs has built in genomics, DNA-based diagnostics and bioinformatics.

What Dr. Omics brought to the discussion

  • Ground-level genomics experience: insights from running DNA testing and genomic analysis services for Indian patients and clients.
  • Skilling the bio-workforce: the gap between India's bioeconomy ambitions and the number of trained genomics and bioinformatics professionals, and how programmes like Dr. Omics Edu help close it.
  • Making genomics accessible: how affordable, India-specific genetic testing can support preventive and personalised healthcare.

"The gap between academia and industry is the biggest most challenge to achieve our target of bioeconomy Agenda" — Dr. Deepshikha Satish, CEO & Founder, Dr. Omics Labs

Why NITI Aayog's bioeconomy agenda matters

India's bioeconomy grew from $10 billion in 2014 to $165.7 billion in 2024, and the national target is $300 billion by 2030 (PIB, March 2025). Genomics sits at the centre of that growth.

The Union Cabinet approved the BioE3 Policy (Biotechnology for Economy, Environment and Employment) on 24 August 2024. It aims to grow biomanufacturing, support a circular bioeconomy and expand India's skilled biotech workforce (PIB).

NITI Aayog helps turn goals like these into roadmaps. It brings together ministries, scientists and industry to decide what India needs: infrastructure, regulation, investment and, above all, trained people.

That last need is where Dr. Omics comes in. A $300 billion bioeconomy needs thousands of professionals who can read a genome, analyse sequencing data and explain genetic results to patients. Dr. Omics Labs works on this daily, and Dr. Omics Edu trains the people India will need.

What this means for Dr. Omics Edu learners

When you study at Dr. Omics Edu, you learn from a team that works in real genomics labs and contributes to national policy conversations. That combination is rare in online education.

  • Curriculum aligned with national priorities: our courses track where India's bioeconomy is heading, so your skills match what employers and research institutions will need through 2030.
  • Taught by practitioners: lessons draw on real DNA testing, variant interpretation and bioinformatics work done at Dr. Omics Labs.
  • Industry-ready skills: [list flagship courses, e.g. Clinical Genomics, Bioinformatics with Python, NGS Data Analysis, Genetic Counselling].
  • Mentorship from recognised experts: learners get guidance from professionals whose work is valued at the policy level.
  • Career relevance: genomics, biomanufacturing and precision medicine are named growth areas in India's bioeconomy plans, and these are the fields our learners prepare for.

Frequently asked questions

Each answer opens with a direct, quotable sentence so search engines and AI assistants can lift it as a featured answer.

What is Dr. Omics Labs?

Dr. Omics Labs is an Indian genomics company that offers DNA testing, genetic analysis and bioinformatics services under the tagline "The Doctor of your DNA". Its education arm, Dr. Omics Edu, trains students and professionals in genomics and bioinformatics.

Did Dr. Omics Labs participate in a NITI Aayog meeting?

Yes. Dr. Deepshikha Satish represented Dr. Omics Labs at NITI Aayog in New Delhi , in a discussion on India's bioeconomy roadmap].

Who is Dr. Deepshikha Satish?

Dr. Deepshikha Satish is the CEO & Founder of Dr. Omics Labs. She has 15 years of experience in genomics / molecular biology / bioinformatics.

What is NITI Aayog?

NITI Aayog (National Institution for Transforming India) is the Government of India's apex public policy think tank. It advises the central and state governments and brings experts together to shape national strategy.

What is India's bioeconomy target for 2030?

India aims to grow its bioeconomy to $300 billion by 2030, up from $165.7 billion in 2024. The BioE3 Policy, approved in August 2024, is the main framework for this goal.

Why should I learn genomics with Dr. Omics Edu?

Dr. Omics Edu courses are built and taught by practitioners from Dr. Omics Labs, a company engaged in national-level conversations on India's bioeconomy. You gain practical skills that match where the industry is heading.

Is genomics a good career in India?

Yes. Genomics is a fast-growing field in India, driven by precision medicine, national genome sequencing efforts and the push to reach a $300 billion bioeconomy by 2030. Skilled genomics and bioinformatics professionals are in demand across hospitals, research labs and biotech companies.

Learn genomics from experts shaping India's bioeconomy. Explore Dr. Omics Edu programmes in genomics, bioinformatics and clinical genetics, and build skills for one of India's fastest-growing sectors.

 

 


WhatsApp